Check out our most popular compounded medications! Get Started
Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects and improved patient compliance. These capsules are used to treat conditions such as Allergic Rhinitis, Urticaria, Chronic Idiopathic Urticaria, Atopic Dermatitis, and Seasonal Allergic Rhinitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) is a compounded medication specifically designed to treat a range of allergic conditions, including Allergic Rhinitis, Urticaria, Chronic Idiopathic Urticaria, Seasonal Allergic Rhinitis, and Intermittent Allergic Rhinitis. This formulation is engineered to provide extended relief from symptoms such as sneezing, itching, and a runny nose, which are commonly associated with these conditions.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication, fexofenadine hydrochloride, over an extended period of time. The slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These slow-release capsules are gluten-free, making them suitable for individuals with dietary restrictions or sensitivities.
If you have any questions about Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) or any other medication, please do not hesitate to contact us. We are here to assist you in finding the best treatment for your condition.
Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) are a specialized formulation designed for the treatment of various allergic conditions such as Allergic Rhinitis, Urticaria, Chronic Idiopathic Urticaria, Seasonal Allergic Rhinitis, and Intermittent Allergic Rhinitis. Fexofenadine HCl, the active ingredient, is an antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms.
This formulation is encapsulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the active ingredient over an extended period, offering sustained therapeutic effects. This slow release mechanism not only provides longer-lasting relief from symptoms but also reduces the frequency of dosing, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The capsules are to be taken orally once daily, preferably with food, to ensure optimal absorption. It is crucial to adhere to the recommended dosage and not to exceed it. Fexofenadine HCl is not recommended for use in children under 12 years of age due to the lack of sufficient safety and efficacy data in this age group.
Patients should be advised to consult their healthcare provider if their symptoms persist or worsen, or if they experience any adverse effects. It is always important to maintain open communication with healthcare providers to ensure the safe and appropriate use of this medication.
Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) is a compounded oral medication specifically designed to provide relief from various allergic conditions such as Allergic Rhinitis, Urticaria, Chronic Idiopathic Urticaria, Seasonal Allergic Rhinitis, and Intermittent Allergic Rhinitis. The active ingredient, Fexofenadine HCl, is an antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms.
This particular formulation is encapsulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the active ingredient over an extended period, offering sustained therapeutic effects. This slow release mechanism not only provides longer-lasting relief from symptoms but also reduces the frequency of dosing, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules are gluten-free, making them an ideal choice for individuals with gluten sensitivities or allergies. When taking Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free), it is crucial to follow the doctor's instructions. The capsules should be swallowed whole with a full glass of water, without crushing, chewing, or breaking them. Consistency in the timing of medication intake each day ensures a steady release rate of the medication. Please note that it may take up to two weeks for Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) to reach its full effect.
If you have any queries about this formulation or its mechanism of action, please do not hesitate to contact us.
Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) are a compounded formulation designed to provide sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer that gradually releases the encapsulated medication. This formulation is particularly beneficial for medications requiring a controlled and prolonged release profile, as it reduces dosing frequency and improves patient compliance.
These capsules can be used to treat a variety of conditions, including allergic conjunctivitis, exercise-induced bronchospasm, and pruritus. They can also serve as a prophylactic treatment for patients with a history of recurrent allergic rhinitis or urticaria.
In addition to these uses, Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) can also be used to alleviate symptoms associated with atopic dermatitis, such as itching, redness, and swelling. However, it is important to note that this formulation should not be used to treat acute asthma attacks.
If you have any questions about the use of Fexofenadine HCl 180 mg Slow Release Capsules (Gluten Free) for any other condition, please do not hesitate to reach out for further information.
Fexofenadine HCl 180 mg Slow Release Capsules are a type of medication that is designed to release the active ingredient, Fexofenadine HCl, gradually over an extended period of time. This is achieved through the use of a controlled-release polymer known as Methocel E4M.
The slow release capsule offers sustained therapeutic effects, which means that the medication continues to work over a longer period of time. This can reduce the frequency of dosing and improve patient compliance, particularly for medications that require a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer that is used in the formulation of these capsules. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
Yes, Fexofenadine HCl 180 mg Slow Release Capsules are gluten free. This makes them suitable for individuals with gluten intolerance or celiac disease.
The dosing frequency of Fexofenadine HCl 180 mg Slow Release Capsules is typically less than that of regular capsules due to its slow release formulation. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
"Improved patient compliance" refers to the likelihood of a patient correctly following their prescribed medication regimen. Slow release capsules can improve patient compliance by reducing the number of doses a patient needs to remember to take each day.
While Fexofenadine HCl 180 mg Slow Release Capsules are generally safe for most people, they may not be suitable for everyone. Always consult with your healthcare provider before starting any new medication.
As with any medication, Fexofenadine HCl 180 mg Slow Release Capsules can have potential side effects. Your healthcare provider can provide you with a comprehensive list of potential side effects based on your specific health condition and other medications you may be taking.
It's important to discuss all medications you're currently taking with your healthcare provider before starting Fexofenadine HCl 180 mg Slow Release Capsules. Some medications may interact with Fexofenadine, affecting how it works or increasing the risk of side effects.
If you miss a dose of Fexofenadine HCl 180 mg Slow Release Capsules, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
